| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 421,321 | 413,447 | 460,601 | 573,260 | | Cost of Revenue | 283,112 | 282,665 | 326,589 | 386,557 | | | Gross Profit | 138,209 | 130,782 | 134,012 | 186,703 | | | Operating Expenses | | Research Development | 40,643 |
-
|
-
|
-
| | Selling General and Administrative | 62,804 | 93,123 | 106,165 | 117,016 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,762 | 37,659 | 27,847 | 69,687 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,022 | 1,788 | 2,574 | 3,104 | | Earnings Before Interest And Taxes | 35,784 | 39,447 | 30,421 | 72,791 | | Interest Expense | 3,933 | 4,067 | 4,728 | 4,290 | | Income Before Tax | 31,851 | 35,380 | 25,693 | 68,501 | | Income Tax Expense | 8,297 | 8,782 | (8,100) | 20,539 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,554 | 26,598 | 33,793 | 47,962 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,554 | 26,598 | 33,793 | 47,962 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,554 | $26,598 | $33,793 | $47,962 |
|
0.60% Nasdaq 
Income Statement
